Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA ...

In recent days, Inspire Medical Systems has been hit by Medicare contractors Noridian and CGS unexpectedly removing CPT code 64568 for hypoglossal nerve stimulation, forcing providers toward an ...

Doctors at ENT Head & Neck Specialists have completed the practice’s 100th Berks County procedure of Inspire — an FDA-approved obstructive sleep apnea treatment option for people who cannot use ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with ...

In the fall of last year, I believed that the risk-reward proposition for Inspire Medical (INSP) was improving after shares were lagging, the business became profitable and the FDA granted approval ...

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...

MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...

Inspire Medical Systems, Inc. (NYSE:INSP) ranks among the best medical device stocks to invest in. On October 10, Inspire Medical Systems, Inc. (NYSE:INSP) published clinical data demonstrating the ...

Revenue for full year 2025 is anticipated to be in the range of $940 million to $955 million, a 17% to 19% increase over full year 2024 “We are very pleased with our strong preliminary revenue ...

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading on Wednesday, February 11. Inspire’s management ...